Currency in USD
Earnings Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|
No. of Analysts | 2 | 2 | 5 | 5 |
Avg. Estimate | 0.99 | 1.23 | 4.04 | 4.54 |
Low Estimate | 0.99 | 1.19 | 4 | 4.5 |
High Estimate | 1 | 1.26 | 4.1 | 4.61 |
Year Ago EPS | 0.97 | 1.28 | 3.86 | 4.04 |
Revenue Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|
No. of Analysts | 3 | 3 | 6 | 6 |
Avg. Estimate | 9.66B | 10.75B | 40.67B | 43.18B |
Low Estimate | 9.65B | 10.69B | 40.01B | 42.18B |
High Estimate | 9.67B | 10.84B | 41.55B | 44.96B |
Year Ago Sales | 8.99B | 9.44B | 37.7B | 40.67B |
Sales Growth (year/est) | 7.50% | 13.90% | 7.90% | 6.20% |
Earnings History | 2023-06-29 | 2023-09-29 | 2023-12-30 | 2024-03-30 |
---|
EPS Est. | 0.87 | 1.14 | 0.76 | 0.91 |
EPS Actual | 0.97 | 1.28 | 0.72 | 1.09 |
Difference | 0.1 | 0.14 | -0.04 | 0.18 |
Surprise % | 11.50% | 12.30% | -5.30% | 19.80% |
EPS Trend | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|
Current Estimate | 0.99 | 1.23 | 4.04 | 4.54 |
7 Days Ago | 0.98 | 1.23 | 4.09 | 4.64 |
30 Days Ago | 0.99 | 1.24 | 4.07 | 4.65 |
60 Days Ago | 0.98 | 1.28 | 4.09 | 4.69 |
90 Days Ago | 0.94 | 1.28 | 3.96 | 4.49 |
EPS Revisions | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|
Up Last 7 Days | 1 | N/A | N/A | N/A |
Up Last 30 Days | 1 | N/A | 1 | 1 |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | 1 | 2 | 2 |
Growth Estimates | GSK | Industry | Sector(s) | S&P 500 |
---|
Current Qtr. | 2.10% | N/A | N/A | N/A |
Next Qtr. | -3.90% | N/A | N/A | N/A |
Current Year | 4.70% | N/A | N/A | N/A |
Next Year | 12.40% | N/A | N/A | N/A |
Next 5 Years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 Years (per annum) | -0.77% | N/A | N/A | N/A |